序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
21 17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases US11045967 2005-01-28 US07138396B2 2006-11-21 Timothy J. Guzi; Kamil Paruch; Alan K. Mallams; Jocelyn D. Rivera; Ronald J. Doll; Viyyoor M. Girijavallabhan; Jonathan A. Pachter; Yi-Tsung Liu; Anil K. Saksena
There are disclosed compounds of the formula (I): prodrugs thereof, or pharmaceutically acceptable salts of the compounds or of said prodrugs which are useful as inhibitors of Type 3 17β-Hydroxysteroid Dehydrogenase. Also disclosed are pharmaceutical compositions containing said compounds and their use for the treatment or prevention of androgen dependent diseases.
22 Pyrazine-2-carboxamide derivatives as mGluR5 antagonists JP2007557420 2006-03-02 JP4774410B2 2011-09-14 コルツェヴスキ,サビーネ; フィエイラ,エリック; ポーター,リチャード・ヒュー・フィリップ; ヤーシュケ,ゲオルク
23 Selective estrogen receptor modulators, including phenylsulfonyl group JP2004522648 2003-07-16 JP4656939B2 2011-03-23 オーウェン・ブレンダン・ウォレス; キン・チュウ・フォン; コンラッド・ウィルソン・ハメル; ジェフリー・アラン・ドッジ; ジョージ・サル・ルイス; スコット・アラン・ジョーンズ; スコット・アラン・フランク; ティモシー・アラン・シェパード; ロバート・ディーン・ダリー
24 Pyrazine-2-carboxamide derivatives as mGluR5 antagonists JP2007557420 2006-03-02 JP2008531630A 2008-08-14 コルツェヴスキ,サビーネ; フィエイラ,エリック; ポーター,リチャード・ヒュー・フィリップ; ヤーシュケ,ゲオルク
本発明は、代謝調節型グルタミン酸受容体アンタゴニストとして有用な一般式(I)の新規なピラジン−2−カルボキシアミド誘導体:式(I)(式中、R 1 、R 2およびR 3は、明細書および特許請求の範囲で定義されたとおりである)に関する。
25 PYRAZINE -2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS EP06707356.9 2006-03-02 EP1858862B1 2016-04-20 JAESCHKE, Georg; KOLCZEWSKI, Sabine; PORTER, Richard, Hugh, Philip; VIEIRA, Eric
26 SELECTIVE ESTROGEN RECEPTOR MODULATORS CONTAINING A PHENYLSULFONYL GROUP EP03765254.2 2003-07-16 EP1530470B1 2009-06-10 DALLY, Robert, Dean; DODGE, Jeffrey, Alan; FRANK, Scott, Alan; JONES, Scott, Alan; SHEPHERD, Timothy, Alan; WALLACE, Owen, Brendan; FONG, Kin, Chiu; HUMMEL, Conrad, Wilson; LEWIS, Geroge, Sal
The present invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata.
27 11-BETA HSD1 INHIBITORS EP07717205.4 2007-02-07 EP1981848A2 2008-10-22 XIANG, Jason Shaoyun; SAIAH, Eddine; TAM, Steve Y.; MCKEW, John C.; CHEN, Lihren; IPEK, Manus; LEE, Katherine; LI, Huan-Qui; LI, Jianchang; LI, Wei; MANSOUR, Tarek Suhayl; SURI, Vipin; VARGAS, Richard; WU, Yuchuan; WAN, Zhao-Kui; LEE, Jinbo; BINNUN, Eva; WILSON, Douglas P.
This invention relates to inhibiting 11βHSD1.
28 PYRAZINE -2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS EP06707356.9 2006-03-02 EP1858862A1 2007-11-28 PORTER, Richard, Hugh, Philip; VIEIRA, Eric; JAESCHKE, Georg; KOLCZEWSKI, Sabine
The present invention is concerned with novel pyrazine 2-carboxyamide derivatives of the general formula (I) useful as metabotropic glutamate receptor antagonists: formula (I) wherein R1, R2 and R3 are as defined in the description and claims.
29 NOVEL M3 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS EP04813056.1 2004-12-03 EP1694327A2 2006-08-30 BUSCH-PETERSEN, Jakob; JIN, Jian; PALOVICH, Michael R.; FU, Wei
Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.
30 ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME US15509590 2015-09-25 US20170294590A1 2017-10-12 Doo-Hyeon Moon; Jeong-Eun Yang; Hee-Ryong Kang; Young-Mook Lim; Ji-Song Jun; Hee-Choon Ahn; Jin-Ri Hong; Su-Hyun Lee; Bitnari Kim; Tae-Jin Lee
The present disclosure relates to an organic electroluminescent compound, and an organic electroluminescent material and an organic electroluminescent device comprising the same. The organic electroluminescent compound of the present disclosure has excellent color purity, solubility, and thermal stability. By comprising the organic electroluminescent compound and the organic electroluminescent material of the present disclosure, an organic electroluminescent device showing low driving voltage, excellent current and power efficiencies, and significantly improved lifespan can be provided.
31 Synthesis of photovoltaic conjugated polymers US14640184 2015-03-06 US09783634B2 2017-10-10 Shuangxi Wang; Chenjun Shi; Ruby Chen; Junlian Zhang; Wei Wang; Yue Wu; Hui Huang; Amit Palkar; Ting He
A method of making a fluorothieno[3,4-b]thiophene derivatives and photovoltaic polymers containing same using 3-bromothiophene-2-carboxylic acid as a starting material. This synthetic route provides an easier synthesis as well as greater yield and a purer product, which produces superior results over the prior art less pure products. The resulting materials can be used in a variety of photovoltaic applications and devices, especially solar cells.
32 SYNTHESIS OF PHOTOVOLTAIC CONJUGATED POLYMERS US14640184 2015-03-06 US20150210800A1 2015-07-30 Shuangxi Wang; Chenjun Shi; Ruby Chen; Junlian Zhang; Wei Wang; Yue Wu; Hui Huang; Amit Palkar; Ting He
A method of making a fluorothieno[3,4-b]thiophene derivatives and photovoltaic polymers containing same using 3-bromothiophene-2-carboxylic acid as a starting material. This synthetic route provides an easier synthesis as well as greater yield and a purer product, which produces superior results over the prior art less pure products. The resulting materials can be used in a variety of photovoltaic applications and devices, especially solar cells.
33 Synthesis of photovoltaic conjugated polymers US13764919 2013-02-12 US09006568B2 2015-04-14 Shuangxi Wang; Chenjun Shi; Ruby Chen; Junlian Zhang; Hui Huang; Yue Wu; Wei Wang; Amit Palkar; Ting He
A method of making a fluorothieno[3,4-b]thiophene derivatives and photovoltaic polymers containing same using 3-bromothiophene-2-carboxylic acid as a starting material. This synthetic route provides an easier synthesis as well as greater yield and a purer product, which produces superior results over the prior art less pure products. The resulting materials can be used in a variety of photovoltaic applications and devices, especially solar cells.
34 ARYLOSULFONAMIDES FOR THE TREATMENT OF CNS DISEASES US14338704 2014-07-23 US20140336200A1 2014-11-13 Marcin KOŁACZKOWSKI; Piotr KOWALSKI; Jolanta Jaskowska; Monika MARCINKOWSKA; Katarzyna MITKA; Adam BUCKI; Anna WESOŁOWSKA; Maciej PAWŁOWSKI
Arylsulphonamide derivatives of formula (I) and pharmaceutically acceptable salts thereof. The compounds may be useful for the treatment and/or prevention of disorders of the central nervous system.
35 PROCESS FOR THE PREPARATION OF AN HIV INTEGRASE INHIBITOR US14045033 2013-10-03 US20140094610A1 2014-04-03 Wenjie LI; Philomen DECROOS; Keith R. FANDRICK; Joe Ju GAO; Nizar HADDAD; Zhi-Hui LU; Bo QU; Sonia RODRIGUEZ; Chris H. SENANAYAKE; Yongda ZHANG; Wenjun TANG
The present invention is directed to an improved process for the preparation of Compounds of Formula (I) or salts thereof which are useful in the treatment of HIV infection. In particular, the present invention is directed to an improved process for the preparation of (2S)-2-tert-butoxy-2-(4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetic acid or salt thereof which is useful in the treatment of HIV infection.
36 SYNTHESIS OF PHOTOVOLTAIC CONJUGATED POLYMERS US13764919 2013-02-12 US20130214213A1 2013-08-22 Shuangxi Wang; Chenjun Shi; Ruby Chen; Junlian Zhang; Hui Huang; Yue Wu; Wei Wang; Amit Palkar; Ting He
A method of making a fluorothieno[3,4-b]thiophene derivatives and photovoltaic polymers containing same using 3-bromothiophene-2-carboxylic acid as a starting material. This synthetic route provides an easier synthesis as well as greater yield and a purer product, which produces superior results over the prior art less pure products. The resulting materials can be used in a variety of photovoltaic applications and devices, especially solar cells.
37 Actinic-Ray- or Radiation-Sensitive Resin Composition, Compound and Method of Forming Pattern Using the Composition US13485793 2012-05-31 US20120237874A1 2012-09-20 Shuhei Yamaguchi; Akinori Shibuya
According to one embodiment, an actinic-ray- or radiation-sensitive resin composition includes any of the compounds (A) of general formula (I) below that when exposed to actinic rays or radiation, generates an acid and a resin (B) whose rate of dissolution into an alkali developer is increased by the action of an acid. (The characters used in general formula (I) have the meanings mentioned in the description.)
38 PHOTORESIST COMPOSITION US13025876 2011-02-11 US20110200935A1 2011-08-18 Tatsuro MASUYAMA; Satoshi YAMAGUCHI
The present invention provides a photoresist composition having a sulfonium salt comprising an anion represented by the formula (IA): wherein R1 and R2 independently represent a hydrogen atom, a C1-C12 aliphatic hydrocarbon group, a C3-C20 saturated cyclic hydrocarbon group, a C6-C20 aromatic hydrocarbon group or a C7-C21 aralkyl group, and the aliphatic hydrocarbon group, the saturated cyclic hydrocarbon group, the aromatic hydrocarbon group and the aralkyl group can have one or more substituents selected from the group consisting of a hydroxyl group, a cyano group, a fluorine atom, a trifluoromethyl group and a nitro group, and one or more —CH2— in the aliphatic hydrocarbon group can be replaced by —O— or —CO—, or R1 and R2 are bonded each other to form a C4-C20 nitrogen-containing ring together with the nitrogen atom to which they are bonded, an acrylic resin having an acid-labile group and being insoluble or poorly soluble in an aqueous alkali solution but becoming soluble in an aqueous alkali solution by the action of an acid, and an acid generator.
39 Pyrazine-2-carboxyamide derivatives US12470554 2009-05-22 US07947685B2 2011-05-24 Georg Jaeschke; Sabine Kolczewski; Richard Hugh Philip Porter; Eric Vieira
The present invention is concerned with novel pyrazine 2-carboxyamide derivatives of formula (I) wherein R1, R2 and R3 are as defined in the specification. These compounds are useful for the treatment of CNS disorders.
40 ORGANIC DYE USED IN DYE-SENSITIZED SOLAR CELL US12958609 2010-12-02 US20110077408A1 2011-03-31 Marappan Velusamy; Koilpitchai R. Justin Thomas; Jiann T'suen Lin; Kuo-Chuan Ho; Ying-Chan Hsu
An organic dye used in a dye-sensitized solar cell is described, having general formula (1): D-Sp1-Ch-Sp2-Acc-Y  (1) wherein the groups D, Ch, Acc and Y are conjugate with each other, the group D is a donor group, the group Ch is a chromophore rendering low HOMO-LUMO gap or a polyaromatic chromophore, the group Acc is an acceptor group, the group Y is an anchoring group, and each of Sp1 and Sp2 represents a single bond or a spacer group allowing conjugation between the groups D and Ch or between the groups Ch and Acc.
QQ群二维码
意见反馈